Understanding Azee Rediuse
Azee Rediuse 200 mg is a macrolide antibiotic research formulation manufactured by Cipla, containing azithromycin as the active pharmaceutical ingredient. This antibiotic compound belongs to the azalide subclass of macrolides and demonstrates broad-spectrum antimicrobial activity against various gram-positive and gram-negative bacterial strains in laboratory investigations. Research applications focus on studying bacterial susceptibility patterns, resistance mechanisms, and pharmacokinetic properties of this well-established antibiotic agent. Stroid UK Shop provides access to pharmaceutical-grade compounds for academic and commercial laboratory studies examining antimicrobial efficacy.
Laboratory Applications
Researchers investigate Azee Rediuse for antimicrobial susceptibility testing, evaluating its effectiveness against respiratory pathogens, skin and soft tissue bacterial isolates, and sexually transmitted bacterial infections in controlled laboratory environments. The compound’s unique pharmacological profile, including its extended half-life and intracellular accumulation properties, makes it valuable for studying antibiotic persistence and tissue distribution patterns. Studies examine its mechanism of action through protein synthesis inhibition at the 50S ribosomal subunit level. Antibiotic research compounds enable comprehensive investigations into bacterial resistance development and therapeutic optimization strategies.
Product Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Azithromycin |
| Strength | 200 mg per unit |
| Manufacturer | Cipla Pharmaceuticals |
| Formulation | Rediuse preparation |
| CAS Number | 83905-01-5 |
| Molecular Formula | C₃₈H₇₂N₂O₁₂ |
| Molecular Weight | 748.98 g/mol |
| Storage Conditions | Room temperature, dry environment |
This pharmaceutical formulation undergoes rigorous quality control testing to ensure consistent potency and purity standards for research applications. Investigators studying antimicrobial compounds often compare azithromycin efficacy against other research chemicals available through selective androgen receptor modulators and peptide research compounds when examining multi-pathway therapeutic interventions.
Research Compliance
Azee Rediuse 200 mg is supplied exclusively for in-vitro research purposes and laboratory investigations. This product is not intended for human consumption, clinical use, or any therapeutic applications outside controlled research environments. Researchers must maintain proper laboratory protocols and regulatory compliance when handling this pharmaceutical research compound.
